Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial
Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective. Th...
Saved in:
| Published in | American journal of obstetrics and gynecology Vol. 222; no. 3; pp. 249.e1 - 249.e10 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.03.2020
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0002-9378 1097-6868 1085-8709 1097-6868 |
| DOI | 10.1016/j.ajog.2019.09.036 |
Cover
| Abstract | Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective.
The purpose of this study was to compare the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer.
The Laparoscopic Approach to Carcinoma of the Cervix trial was a multinational, randomized noninferiority trial that was conducted between 2008 and 2017, in which surgeons from 33 tertiary gynecologic cancer centers in 24 countries randomly assigned 631 women with International Federation of Gynecology and Obstetrics 2009 stage IA1 with lymph-vascular invasion to IB1 cervical cancer to undergo minimally invasive (n = 319) or open radical hysterectomy (n = 312). The Laparoscopic Approach to Carcinoma of the Cervix trial was suspended for enrolment in September 2017 because of an increased risk of recurrence and death in the minimally invasive surgery group. Here we report on a secondary outcome measure: the incidence of intra- and postoperative adverse events within 6 months after surgery.
Of 631 randomly assigned patients, 536 (85%; mean age, 46.0 years) met inclusion criteria for this analysis; 279 (52%) underwent minimally invasive radical hysterectomy, and 257 (48%) underwent open radical hysterectomy. Of those, 300 (56%), 91 (16.9%), and 69 (12.8%) experienced at least 1 grade ≥2 or ≥3 or a serious adverse event, respectively. The incidence of intraoperative grade ≥2 adverse events was 12% (34/279 patients) in the minimally invasive group vs 10% (26/257) in the open group (difference, 2.1%; 95% confidence interval, –3.3 to 7.4%; P=.45). The overall incidence of postoperative grade ≥2 adverse events was 54% (152/279 patients) in the minimally invasive group vs 48% (124/257) in the open group (difference, 6.2%; 95% confidence interval, –2.2 to 14.7%; P=.14).
For early cervical cancer, the use of minimally invasive compared with open radical hysterectomy resulted in a similar overall incidence of intraoperative or postoperative adverse events. |
|---|---|
| AbstractList | Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective.
The purpose of this study was to compare the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer.
The Laparoscopic Approach to Carcinoma of the Cervix trial was a multinational, randomized noninferiority trial that was conducted between 2008 and 2017, in which surgeons from 33 tertiary gynecologic cancer centers in 24 countries randomly assigned 631 women with International Federation of Gynecology and Obstetrics 2009 stage IA1 with lymph-vascular invasion to IB1 cervical cancer to undergo minimally invasive (n = 319) or open radical hysterectomy (n = 312). The Laparoscopic Approach to Carcinoma of the Cervix trial was suspended for enrolment in September 2017 because of an increased risk of recurrence and death in the minimally invasive surgery group. Here we report on a secondary outcome measure: the incidence of intra- and postoperative adverse events within 6 months after surgery.
Of 631 randomly assigned patients, 536 (85%; mean age, 46.0 years) met inclusion criteria for this analysis; 279 (52%) underwent minimally invasive radical hysterectomy, and 257 (48%) underwent open radical hysterectomy. Of those, 300 (56%), 91 (16.9%), and 69 (12.8%) experienced at least 1 grade ≥2 or ≥3 or a serious adverse event, respectively. The incidence of intraoperative grade ≥2 adverse events was 12% (34/279 patients) in the minimally invasive group vs 10% (26/257) in the open group (difference, 2.1%; 95% confidence interval, –3.3 to 7.4%; P=.45). The overall incidence of postoperative grade ≥2 adverse events was 54% (152/279 patients) in the minimally invasive group vs 48% (124/257) in the open group (difference, 6.2%; 95% confidence interval, –2.2 to 14.7%; P=.14).
For early cervical cancer, the use of minimally invasive compared with open radical hysterectomy resulted in a similar overall incidence of intraoperative or postoperative adverse events. Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective.BACKGROUNDStandard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective.The purpose of this study was to compare the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer.OBJECTIVEThe purpose of this study was to compare the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer.The Laparoscopic Approach to Carcinoma of the Cervix trial was a multinational, randomized noninferiority trial that was conducted between 2008 and 2017, in which surgeons from 33 tertiary gynecologic cancer centers in 24 countries randomly assigned 631 women with International Federation of Gynecology and Obstetrics 2009 stage IA1 with lymph-vascular invasion to IB1 cervical cancer to undergo minimally invasive (n = 319) or open radical hysterectomy (n = 312). The Laparoscopic Approach to Carcinoma of the Cervix trial was suspended for enrolment in September 2017 because of an increased risk of recurrence and death in the minimally invasive surgery group. Here we report on a secondary outcome measure: the incidence of intra- and postoperative adverse events within 6 months after surgery.STUDY DESIGNThe Laparoscopic Approach to Carcinoma of the Cervix trial was a multinational, randomized noninferiority trial that was conducted between 2008 and 2017, in which surgeons from 33 tertiary gynecologic cancer centers in 24 countries randomly assigned 631 women with International Federation of Gynecology and Obstetrics 2009 stage IA1 with lymph-vascular invasion to IB1 cervical cancer to undergo minimally invasive (n = 319) or open radical hysterectomy (n = 312). The Laparoscopic Approach to Carcinoma of the Cervix trial was suspended for enrolment in September 2017 because of an increased risk of recurrence and death in the minimally invasive surgery group. Here we report on a secondary outcome measure: the incidence of intra- and postoperative adverse events within 6 months after surgery.Of 631 randomly assigned patients, 536 (85%; mean age, 46.0 years) met inclusion criteria for this analysis; 279 (52%) underwent minimally invasive radical hysterectomy, and 257 (48%) underwent open radical hysterectomy. Of those, 300 (56%), 91 (16.9%), and 69 (12.8%) experienced at least 1 grade ≥2 or ≥3 or a serious adverse event, respectively. The incidence of intraoperative grade ≥2 adverse events was 12% (34/279 patients) in the minimally invasive group vs 10% (26/257) in the open group (difference, 2.1%; 95% confidence interval, -3.3 to 7.4%; P=.45). The overall incidence of postoperative grade ≥2 adverse events was 54% (152/279 patients) in the minimally invasive group vs 48% (124/257) in the open group (difference, 6.2%; 95% confidence interval, -2.2 to 14.7%; P=.14).RESULTSOf 631 randomly assigned patients, 536 (85%; mean age, 46.0 years) met inclusion criteria for this analysis; 279 (52%) underwent minimally invasive radical hysterectomy, and 257 (48%) underwent open radical hysterectomy. Of those, 300 (56%), 91 (16.9%), and 69 (12.8%) experienced at least 1 grade ≥2 or ≥3 or a serious adverse event, respectively. The incidence of intraoperative grade ≥2 adverse events was 12% (34/279 patients) in the minimally invasive group vs 10% (26/257) in the open group (difference, 2.1%; 95% confidence interval, -3.3 to 7.4%; P=.45). The overall incidence of postoperative grade ≥2 adverse events was 54% (152/279 patients) in the minimally invasive group vs 48% (124/257) in the open group (difference, 6.2%; 95% confidence interval, -2.2 to 14.7%; P=.14).For early cervical cancer, the use of minimally invasive compared with open radical hysterectomy resulted in a similar overall incidence of intraoperative or postoperative adverse events.CONCLUSIONFor early cervical cancer, the use of minimally invasive compared with open radical hysterectomy resulted in a similar overall incidence of intraoperative or postoperative adverse events. |
| Author | Vieira, Marcelo Buda, Alessandro Frumovitz, Michael Zhao, Hongqin Coleman, Robert L. Asher, Rebecca Obermair, Andreas Chetty, Naven Zhu, Tao Nicklin, James Yao, Shuzhong Tsunoda, Audrey Lopez, Aldo Robledo, Kristy P. Ramirez, Pedro T. Gebski, Val Bernadini, Marcus Q. Walker, Joan Tamura, Mariano Pareja, Rene Spirtos, Nick M. Moretti-Marques, Renato Behan, Vanessa Ribeiro, Reitan Isla, David Salvo, Gloria Rendon, Gabriel |
| Author_xml | – sequence: 1 givenname: Andreas surname: Obermair fullname: Obermair, Andreas email: Obermair@powerup.com.au organization: Queensland Centre for Gynaecological Cancer Research, University of Queensland, Centre for Clinical Research, RBWH, Herston, QLD Australia – sequence: 2 givenname: Rebecca surname: Asher fullname: Asher, Rebecca organization: National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW Australia – sequence: 3 givenname: Rene surname: Pareja fullname: Pareja, Rene organization: Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogotá and Clínica de Oncología Astorga, Medellín, Colombia – sequence: 4 givenname: Michael surname: Frumovitz fullname: Frumovitz, Michael organization: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX – sequence: 5 givenname: Aldo surname: Lopez fullname: Lopez, Aldo organization: Department of Gynecologic Surgery, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru – sequence: 6 givenname: Renato surname: Moretti-Marques fullname: Moretti-Marques, Renato organization: Gynecologic Oncology Division, Oncologic Center, Hospital Israelita Albert Einstein, São Paulo-SP, Brazil – sequence: 7 givenname: Gabriel orcidid: 0000-0002-7536-0567 surname: Rendon fullname: Rendon, Gabriel organization: Instituto de Cancerologia–Las Americas, Medellín, Colombia – sequence: 8 givenname: Reitan surname: Ribeiro fullname: Ribeiro, Reitan organization: Department of Surgery, Erasto Gaertner Hospital, Curitiba, Brazil – sequence: 9 givenname: Audrey surname: Tsunoda fullname: Tsunoda, Audrey organization: Department of Surgery, Erasto Gaertner Hospital, Curitiba, Brazil – sequence: 10 givenname: Vanessa surname: Behan fullname: Behan, Vanessa organization: Queensland Centre for Gynaecological Cancer Research, University of Queensland, Centre for Clinical Research, RBWH, Herston, QLD Australia – sequence: 11 givenname: Alessandro surname: Buda fullname: Buda, Alessandro organization: Unit of Gynecologic Oncology Surgery, Department of Obstetrics and Gynecology, San Gerardo Hospital, Monza MB, Italy – sequence: 12 givenname: Marcus Q. orcidid: 0000-0001-7022-8308 surname: Bernadini fullname: Bernadini, Marcus Q. organization: Department of Gynecologic Oncology, Princess Margaret Cancer Center, Ontario, Canada – sequence: 13 givenname: Hongqin surname: Zhao fullname: Zhao, Hongqin organization: Department of Gynecology, First Affiliated Hospital of Wenzhou Medical College, Ouhai, Wenzhou, China – sequence: 14 givenname: Marcelo surname: Vieira fullname: Vieira, Marcelo organization: Department of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, Brazil – sequence: 15 givenname: Joan surname: Walker fullname: Walker, Joan organization: Department of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma, Norman, OK – sequence: 16 givenname: Nick M. surname: Spirtos fullname: Spirtos, Nick M. organization: Division of Gynecologic Oncology, Women’s Cancer Center of Nevada, LV – sequence: 17 givenname: Shuzhong surname: Yao fullname: Yao, Shuzhong organization: Department of Obstetrics and Gynecology, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China – sequence: 18 givenname: Naven surname: Chetty fullname: Chetty, Naven organization: Department of Gynecologic Oncology, Mater Health Services Brisbane, South Brisbane, QLD, Australia – sequence: 19 givenname: Tao surname: Zhu fullname: Zhu, Tao organization: Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China – sequence: 20 givenname: David surname: Isla fullname: Isla, David organization: Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Mexico – sequence: 21 givenname: Mariano surname: Tamura fullname: Tamura, Mariano organization: Gynecologic Oncology Division, Oncologic Center, Hospital Israelita Albert Einstein, São Paulo-SP, Brazil – sequence: 22 givenname: James surname: Nicklin fullname: Nicklin, James organization: Department of Gynaecologic Oncology, Royal Brisbane and Women’s Hospital and The University of Queensland, Brisbane, QLD, Australia – sequence: 23 givenname: Kristy P. surname: Robledo fullname: Robledo, Kristy P. organization: National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW Australia – sequence: 24 givenname: Val surname: Gebski fullname: Gebski, Val organization: National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW Australia – sequence: 25 givenname: Robert L. surname: Coleman fullname: Coleman, Robert L. organization: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX – sequence: 26 givenname: Gloria orcidid: 0000-0002-1753-1778 surname: Salvo fullname: Salvo, Gloria organization: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX – sequence: 27 givenname: Pedro T. surname: Ramirez fullname: Ramirez, Pedro T. organization: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31586602$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkk1vFSEUhompsbfVP-DCsHQzVz46DNO4MY0fTZq40TXhwhnlysAVZqYZ_4X_WPBWF11UExI44X0O57yHM3QSYgCEnlOypYSKV_ut3scvW0ZovyVlcfEIbSjpu0ZIIU_QhhDCmp538hSd5byvIevZE3TKaSuFIGyDfl4H4ywEAzgOWNsFUgYMC4QpYxfw6IIbtfdrCRad3QJ4yTgeIOCkrTPa469rniCBmeJYVRh0KnIDafl9bXRJni5xgjz7krQ-U9hg4-h-gMUmhilF78txSk77p-jxoH2GZ3f7Ofr87u2nqw_Nzcf311dvbhpz0dKpaaFl4sJSacxgaW92Oz2QTtBO81aI3dD20INogQvZUqG7noJkhvUDpYLwQfBzxI9553DQ623pUR1S6TWtihJVDVZ7VQ1W1WBFyuKVenmkDil-nyFPanTZgPc6QJyzYpxQKUXXVumLO-m8G8H-zf7H_CKQR4FJMecEgzJu0pOrhmjnHy6D3UP_q_bXRwiKrYuDpLJxdfTW1fEpG93D-OU93PjyO8qMv8H6L_gXfpDWZw |
| CitedBy_id | crossref_primary_10_1007_s00432_024_05773_8 crossref_primary_10_1097_JS9_0000000000001980 crossref_primary_10_1016_j_ygyno_2021_10_073 crossref_primary_10_1186_s12885_024_13090_z crossref_primary_10_3802_jgo_2024_35_e49 crossref_primary_10_3390_polym16081105 crossref_primary_10_1016_j_ejogrb_2022_06_004 crossref_primary_10_1007_s11701_024_01863_4 crossref_primary_10_3390_cancers14030575 crossref_primary_10_1016_j_tru_2021_100038 crossref_primary_10_1136_ijgc_2020_001663 crossref_primary_10_12677_ACM_2023_1371646 crossref_primary_10_1136_ijgc_2023_004657 crossref_primary_10_1186_s12893_024_02716_5 crossref_primary_10_3390_ijerph191811641 crossref_primary_10_3390_jcm13051496 crossref_primary_10_1016_j_fertnstert_2020_07_038 crossref_primary_10_1111_jog_15633 crossref_primary_10_1136_ijgc_2022_004092 crossref_primary_10_1016_j_bpobgyn_2023_102434 crossref_primary_10_1007_s11912_020_0876_1 crossref_primary_10_1136_ijgc_2020_001776 crossref_primary_10_1002_adhm_202302714 crossref_primary_10_3802_jgo_2024_35_e23 crossref_primary_10_1007_s00761_024_01560_9 crossref_primary_10_1177_10760296241240747 crossref_primary_10_3390_jcm13154351 crossref_primary_10_1111_iwj_13962 crossref_primary_10_1111_iwj_14535 crossref_primary_10_3390_diagnostics14050559 crossref_primary_10_1136_ijgc_2021_002577 crossref_primary_10_1002_ijgo_70028 crossref_primary_10_3390_jcm12175677 crossref_primary_10_1136_ijgc_2020_001406 crossref_primary_10_3802_jgo_2021_32_e10 crossref_primary_10_1186_s12885_022_10395_9 crossref_primary_10_1016_j_ijgc_2025_101760 crossref_primary_10_1186_s12893_024_02713_8 crossref_primary_10_1177_14574969231186283 crossref_primary_10_1097_AOG_0000000000005810 crossref_primary_10_4103_ijmr_IJMR_4240_20 crossref_primary_10_1007_s00404_021_06185_6 crossref_primary_10_1007_s10147_025_02735_z crossref_primary_10_1186_s12957_023_03076_9 crossref_primary_10_1016_j_ygyno_2020_05_009 crossref_primary_10_1016_j_jogoh_2022_102364 crossref_primary_10_1016_j_jmig_2024_07_002 crossref_primary_10_3390_cancers14163863 crossref_primary_10_31260_RepertMedCir_01217372_1261 crossref_primary_10_1016_j_ejso_2024_108518 crossref_primary_10_1056_NEJMe2400423 crossref_primary_10_17816_aog643484 crossref_primary_10_1016_j_ajog_2024_08_008 crossref_primary_10_1002_ijgo_13141 crossref_primary_10_1007_s00129_022_04924_7 crossref_primary_10_1097_PGP_0000000000000735 crossref_primary_10_1016_j_asjsur_2022_06_141 crossref_primary_10_1136_ijgc_2021_003244 crossref_primary_10_1136_ijgc_2023_004593 crossref_primary_10_3390_diagnostics14242782 crossref_primary_10_1007_s11654_021_00294_z crossref_primary_10_31083_j_ceog5002032 crossref_primary_10_1038_s41598_021_89071_0 crossref_primary_10_3389_fsurg_2025_1587048 crossref_primary_10_3390_curroncol29020093 crossref_primary_10_1016_j_ejso_2021_03_238 crossref_primary_10_7759_cureus_43035 crossref_primary_10_1016_j_jmig_2020_12_023 crossref_primary_10_1016_j_ygyno_2020_06_508 crossref_primary_10_1016_j_cca_2019_11_008 crossref_primary_10_1016_j_ygyno_2022_07_022 crossref_primary_10_3390_cancers16223806 crossref_primary_10_1097_RD9_0000000000000106 crossref_primary_10_1245_s10434_020_09265_0 crossref_primary_10_1016_j_ygyno_2021_05_028 crossref_primary_10_3389_fonc_2024_1404831 crossref_primary_10_1016_j_ygyno_2020_05_029 crossref_primary_10_3390_ijms23095134 crossref_primary_10_31083_j_ceog5002044 crossref_primary_10_1371_journal_pone_0253143 crossref_primary_10_1016_j_jmig_2022_03_014 crossref_primary_10_3390_cancers15051570 crossref_primary_10_1016_j_ygyno_2023_04_030 crossref_primary_10_1016_j_jogoh_2020_102031 crossref_primary_10_1016_j_jogoh_2020_101980 crossref_primary_10_1007_s00404_021_06248_8 crossref_primary_10_1111_aogs_14852 crossref_primary_10_3389_fendo_2023_1280631 crossref_primary_10_1007_s10815_021_02245_7 crossref_primary_10_1016_j_jmig_2022_05_021 crossref_primary_10_1155_ecc_9573736 crossref_primary_10_1111_1471_0528_17408 crossref_primary_10_3390_jcm10173761 crossref_primary_10_1007_s00404_020_05798_7 crossref_primary_10_1007_s00404_021_06082_y crossref_primary_10_1136_ijgc_2022_003654 crossref_primary_10_1016_j_jmig_2024_12_009 crossref_primary_10_1136_ijgc_2020_001794 |
| Cites_doi | 10.1016/S0039-6109(05)70167-5 10.1016/j.ygyno.2006.10.033 10.1200/JCO.2009.22.3248 10.1089/lap.2017.0022 10.1016/j.ejso.2016.07.017 10.3322/caac.21551 10.1002/rcs.152 10.3322/caac.21492 10.1056/NEJMoa1806395 10.1016/j.jmig.2008.06.013 10.1016/j.ygyno.2015.06.009 10.1186/s12885-015-1818-4 10.1371/journal.pone.0193033 10.1089/lap.2015.0390 10.6004/jnccn.2019.0001 |
| ContentType | Journal Article |
| Copyright | 2019 Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2019 – notice: Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY |
| DOI | 10.1016/j.ajog.2019.09.036 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-6868 |
| EndPage | 249.e10 |
| ExternalDocumentID | oai:repositorio.inen.pe:INEN/130 31586602 10_1016_j_ajog_2019_09_036 S0002937819311652 |
| Genre | Clinical Trial, Phase III Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: National Cancer Institute grantid: P30CA016672 funderid: https://doi.org/10.13039/100000054 – fundername: Department of Gynecologic Oncology and Reproductive Medicine – fundername: The University of Texas MD Anderson Cancer Center – fundername: NCI NIH HHS grantid: P30 CA016672 |
| GroupedDBID | --- --K --M -ET .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1CY 1P~ 1~. 1~5 23M 2KS 354 3O- 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 6J9 7-5 85S 8F7 8P~ AAEDT AAEDW AAIKC AAIKJ AAKOC AALRI AAMNW AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYJJ AAYWO ABBQC ABCQX ABDPE ABFNM ABFRF ABJNI ABMAC ABMZM ABOCM ABPMR ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFCHL AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGNAY AGQPQ AGUBO AGYEJ AHDLI AI. AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 C5W CAG COF CS3 EBS EFJIC EFKBS EFLBG EJD EO8 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IH2 IHE J1W K-O KOM LPU M41 MO0 N4W N9A NEJ NQ- O-L O9- OAUVE OBH OCB OGEVE OHH OHT OMK OQ. OVD P-8 P-9 P2P PC. PH~ Q38 R2- ROL RPZ RXW SDF SEL SES SEW SJN SPCBC SSH SSZ T5K TAE TEORI TWZ UDS UGJ UHB UHS UHU UKR UNMZH UV1 VH1 VVN WH7 WOQ WOW X6Y X7M XFW YFH YOC YYQ YZZ Z5R ZGI ZXP ZY1 ~G- ~H1 ~HD AACTN AAIAV ABLVK ABYKQ ADOJD AFCTW AFDAS AFKWA AHPSJ AJBFU AJOXV AMFUW G8K LCYCR NCXOZ RIG ZA5 AAYXX CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY |
| ID | FETCH-LOGICAL-c451t-5e5264d18ccfd19cbbaf07617a3566bf59e9e65e368516a791e82c29f11603f63 |
| IEDL.DBID | .~1 |
| ISSN | 0002-9378 1097-6868 1085-8709 |
| IngestDate | Sun Oct 26 03:18:38 EDT 2025 Sun Sep 28 08:32:27 EDT 2025 Mon Jul 21 06:01:20 EDT 2025 Wed Oct 01 03:54:37 EDT 2025 Thu Apr 24 22:59:49 EDT 2025 Fri Feb 23 02:50:29 EST 2024 Tue Oct 14 19:36:04 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | radical hysterectomy complication laparoscopic hysterectomy robotic hysterectomy minimally invasive surgery LACC hysterectomy postoperative adverse event cervical cancer |
| Language | English |
| License | Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved. other-oa |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c451t-5e5264d18ccfd19cbbaf07617a3566bf59e9e65e368516a791e82c29f11603f63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-7536-0567 0000-0002-1753-1778 0000-0001-7022-8308 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=http://repositorio.inen.pe:8080/handle/INEN/130 |
| PMID | 31586602 |
| PQID | 2301886756 |
| PQPubID | 23479 |
| ParticipantIDs | unpaywall_primary_10_1016_j_ajog_2019_09_036 proquest_miscellaneous_2301886756 pubmed_primary_31586602 crossref_citationtrail_10_1016_j_ajog_2019_09_036 crossref_primary_10_1016_j_ajog_2019_09_036 elsevier_sciencedirect_doi_10_1016_j_ajog_2019_09_036 elsevier_clinicalkey_doi_10_1016_j_ajog_2019_09_036 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | March 2020 2020-03-00 20200301 |
| PublicationDateYYYYMMDD | 2020-03-01 |
| PublicationDate_xml | – month: 03 year: 2020 text: March 2020 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | American journal of obstetrics and gynecology |
| PublicationTitleAlternate | Am J Obstet Gynecol |
| PublicationYear | 2020 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Koh, Abu-Rustum, Bean (bib3) 2019; 17 Shazly, Murad, Dowdy, Gostout, Famuyide (bib17) 2015; 138 Zhao, Hang, Xiong, Zhang (bib7) 2017; 27 Nevis, Vali, Higgins, Dhalla, Urbach, Bernardini (bib15) 2017; 11 Frumovitz, Ramirez (bib11) 2007; 104 Cao, Feng, Huang, Wan, Liu (bib5) 2015; 25 Wang, Deng, Xu, Zhang, Liang (bib6) 2015; 15 Jin, Liu, Chen, Chen, Ren (bib14) 2018; 13 Sert, Abeler (bib12) 2007; 3 Obermair, Gebski, Frumovitz (bib9) 2008; 15 Bray, Ferlay, Soerjomataram, Siegel, Torre, Jemal (bib1) 2018; 68 Walker, Piedmonte, Spirtos (bib18) 2009; 27 (bib13) 2006 Siegel, Miller, Jemal (bib2) 2019; 69 Park, Yun, Kim, Lee (bib16) 2017; 43 Ramirez, Frumovitz, Pareja (bib8) 2018; 379 Piver, Rutledge (bib10) 1974; 44 Abu-Rustum, Hoskins (bib4) 2001; 81 Sert (10.1016/j.ajog.2019.09.036_bib12) 2007; 3 Piver (10.1016/j.ajog.2019.09.036_bib10) 1974; 44 Siegel (10.1016/j.ajog.2019.09.036_bib2) 2019; 69 Frumovitz (10.1016/j.ajog.2019.09.036_bib11) 2007; 104 Shazly (10.1016/j.ajog.2019.09.036_bib17) 2015; 138 Jin (10.1016/j.ajog.2019.09.036_bib14) 2018; 13 Koh (10.1016/j.ajog.2019.09.036_bib3) 2019; 17 Obermair (10.1016/j.ajog.2019.09.036_bib9) 2008; 15 Abu-Rustum (10.1016/j.ajog.2019.09.036_bib4) 2001; 81 (10.1016/j.ajog.2019.09.036_bib13) 2006 Bray (10.1016/j.ajog.2019.09.036_bib1) 2018; 68 Ramirez (10.1016/j.ajog.2019.09.036_bib8) 2018; 379 Walker (10.1016/j.ajog.2019.09.036_bib18) 2009; 27 Zhao (10.1016/j.ajog.2019.09.036_bib7) 2017; 27 Park (10.1016/j.ajog.2019.09.036_bib16) 2017; 43 Cao (10.1016/j.ajog.2019.09.036_bib5) 2015; 25 Wang (10.1016/j.ajog.2019.09.036_bib6) 2015; 15 Nevis (10.1016/j.ajog.2019.09.036_bib15) 2017; 11 33036734 - Am J Obstet Gynecol. 2020 Nov;223(5):757 |
| References_xml | – volume: 27 start-page: 1132 year: 2017 end-page: 1144 ident: bib7 article-title: Laparoscopic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis publication-title: J Laparoendosc Adv Surg Tech A – volume: 104 start-page: 13 year: 2007 end-page: 16 ident: bib11 article-title: Total laparoscopic radical hysterectomy: surgical technique and instrumentation publication-title: Gynecol Oncol – volume: 15 start-page: 928 year: 2015 ident: bib6 article-title: Laparoscopy versus laparotomy for the management of early stage cervical cancer publication-title: BMC Cancer – volume: 138 start-page: 457 year: 2015 end-page: 471 ident: bib17 article-title: Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis publication-title: Gynecol Oncol – volume: 13 year: 2018 ident: bib14 article-title: Robotic radical hysterectomy is superior to laparoscopic radical hysterectomy and open radical hysterectomy in the treatment of cervical cancer publication-title: PLoS One – year: 2006 ident: bib13 publication-title: National Cancer Institute common terminology criteria for adverse events, version 3.0 (CTCAE) – volume: 11 start-page: 1 year: 2017 end-page: 16 ident: bib15 article-title: Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic review publication-title: J Robot Surg – volume: 15 start-page: 584 year: 2008 end-page: 588 ident: bib9 article-title: A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer publication-title: J Minim Invasive Gynecol – volume: 25 start-page: 990 year: 2015 end-page: 998 ident: bib5 article-title: Prognostic and safety roles in laparoscopic versus abdominal radical hysterectomy in cervical cancer: a meta-analysis publication-title: J Laparoendosc Adv Surg Tech A – volume: 17 start-page: 64 year: 2019 end-page: 84 ident: bib3 article-title: Cervical cancer, Version 3.2019, NCCN clinical practice guidelines in oncology publication-title: J Natl Compr Canc Netw – volume: 81 start-page: 815 year: 2001 end-page: 828 ident: bib4 article-title: Radical abdominal hysterectomy publication-title: Surg Clin North Am – volume: 44 start-page: 265 year: 1974 end-page: 272 ident: bib10 article-title: Five classes of extended hysterectomy for women with cervical cancer publication-title: Obstet Gynecol – volume: 68 start-page: 394 year: 2018 end-page: 424 ident: bib1 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 69 start-page: 7 year: 2019 end-page: 34 ident: bib2 article-title: Cancer statistics, 2019 publication-title: CA Cancer J Clin – volume: 43 start-page: 994 year: 2017 end-page: 1002 ident: bib16 article-title: Surgical and clinical safety and effectiveness of robot-assisted laparoscopic hysterectomy compared to conventional laparoscopy and laparotomy for cervical cancer: a systematic review and meta-analysis publication-title: Eur J Surg Oncol – volume: 3 start-page: 224 year: 2007 end-page: 228 ident: bib12 article-title: Robotic radical hysterectomy in early-stage cervical carcinoma patients, comparing results with total laparoscopic radical hysterectomy cases. The future is now? publication-title: Int J Med Robot – volume: 27 start-page: 5331 year: 2009 end-page: 5336 ident: bib18 article-title: Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2 publication-title: J Clin Oncol – volume: 379 start-page: 1895 year: 2018 end-page: 1904 ident: bib8 article-title: Minimally invasive versus abdominal radical hysterectomy for cervical cancer publication-title: N Engl J Med – volume: 81 start-page: 815 year: 2001 ident: 10.1016/j.ajog.2019.09.036_bib4 article-title: Radical abdominal hysterectomy publication-title: Surg Clin North Am doi: 10.1016/S0039-6109(05)70167-5 – volume: 104 start-page: 13 issue: suppl1 year: 2007 ident: 10.1016/j.ajog.2019.09.036_bib11 article-title: Total laparoscopic radical hysterectomy: surgical technique and instrumentation publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2006.10.033 – volume: 27 start-page: 5331 year: 2009 ident: 10.1016/j.ajog.2019.09.036_bib18 article-title: Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.22.3248 – volume: 27 start-page: 1132 year: 2017 ident: 10.1016/j.ajog.2019.09.036_bib7 article-title: Laparoscopic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis publication-title: J Laparoendosc Adv Surg Tech A doi: 10.1089/lap.2017.0022 – volume: 43 start-page: 994 year: 2017 ident: 10.1016/j.ajog.2019.09.036_bib16 article-title: Surgical and clinical safety and effectiveness of robot-assisted laparoscopic hysterectomy compared to conventional laparoscopy and laparotomy for cervical cancer: a systematic review and meta-analysis publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2016.07.017 – volume: 69 start-page: 7 year: 2019 ident: 10.1016/j.ajog.2019.09.036_bib2 article-title: Cancer statistics, 2019 publication-title: CA Cancer J Clin doi: 10.3322/caac.21551 – volume: 3 start-page: 224 year: 2007 ident: 10.1016/j.ajog.2019.09.036_bib12 article-title: Robotic radical hysterectomy in early-stage cervical carcinoma patients, comparing results with total laparoscopic radical hysterectomy cases. The future is now? publication-title: Int J Med Robot doi: 10.1002/rcs.152 – volume: 68 start-page: 394 year: 2018 ident: 10.1016/j.ajog.2019.09.036_bib1 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21492 – volume: 379 start-page: 1895 year: 2018 ident: 10.1016/j.ajog.2019.09.036_bib8 article-title: Minimally invasive versus abdominal radical hysterectomy for cervical cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1806395 – volume: 15 start-page: 584 year: 2008 ident: 10.1016/j.ajog.2019.09.036_bib9 article-title: A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer publication-title: J Minim Invasive Gynecol doi: 10.1016/j.jmig.2008.06.013 – volume: 138 start-page: 457 year: 2015 ident: 10.1016/j.ajog.2019.09.036_bib17 article-title: Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2015.06.009 – volume: 11 start-page: 1 year: 2017 ident: 10.1016/j.ajog.2019.09.036_bib15 article-title: Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic review publication-title: J Robot Surg – volume: 15 start-page: 928 year: 2015 ident: 10.1016/j.ajog.2019.09.036_bib6 article-title: Laparoscopy versus laparotomy for the management of early stage cervical cancer publication-title: BMC Cancer doi: 10.1186/s12885-015-1818-4 – volume: 13 year: 2018 ident: 10.1016/j.ajog.2019.09.036_bib14 article-title: Robotic radical hysterectomy is superior to laparoscopic radical hysterectomy and open radical hysterectomy in the treatment of cervical cancer publication-title: PLoS One doi: 10.1371/journal.pone.0193033 – volume: 25 start-page: 990 year: 2015 ident: 10.1016/j.ajog.2019.09.036_bib5 article-title: Prognostic and safety roles in laparoscopic versus abdominal radical hysterectomy in cervical cancer: a meta-analysis publication-title: J Laparoendosc Adv Surg Tech A doi: 10.1089/lap.2015.0390 – volume: 44 start-page: 265 year: 1974 ident: 10.1016/j.ajog.2019.09.036_bib10 article-title: Five classes of extended hysterectomy for women with cervical cancer publication-title: Obstet Gynecol – year: 2006 ident: 10.1016/j.ajog.2019.09.036_bib13 – volume: 17 start-page: 64 year: 2019 ident: 10.1016/j.ajog.2019.09.036_bib3 article-title: Cervical cancer, Version 3.2019, NCCN clinical practice guidelines in oncology publication-title: J Natl Compr Canc Netw doi: 10.6004/jnccn.2019.0001 – reference: 33036734 - Am J Obstet Gynecol. 2020 Nov;223(5):757 |
| SSID | ssj0002292 |
| Score | 2.6196978 |
| Snippet | Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence... |
| SourceID | unpaywall proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 249.e1 |
| SubjectTerms | Adenocarcinoma - pathology Adenocarcinoma - surgery Blood Loss, Surgical - statistics & numerical data Blood Transfusion - statistics & numerical data Body Mass Index Carcinoma, Adenosquamous - pathology Carcinoma, Adenosquamous - surgery Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - surgery cervical cancer complication Conversion to Open Surgery - statistics & numerical data Female Humans hysterectomy Hysterectomy - adverse effects Hysterectomy - methods Intraoperative Complications - classification Intraoperative Complications - epidemiology LACC laparoscopic hysterectomy Laparoscopy Length of Stay - statistics & numerical data Lymph Node Excision Middle Aged minimally invasive surgery Operative Time postoperative adverse event Postoperative Complications - classification Postoperative Complications - epidemiology radical hysterectomy Risk Factors robotic hysterectomy Robotic Surgical Procedures Uterine Cervical Neoplasms - pathology Uterine Cervical Neoplasms - surgery |
| SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwELZGJ4F4YPwaFAEyEm-QrW5i1-FtmjYNpFV7oNJ4smzHhm5pMjXN0PZf8B9zF8cV0sQYUh9S1Zcmype77-zzd4S8T_mo8NrqxEL0SDKZmUT7LEsMpA4TX-ROdhP6x1NxNMu-nPLTDRI70-FEeTNHeYwaiKerIKcPyodBc2D38_Rgugtu9x7ZFBzI94BszqYne98iyYVgK2NJPSAx747zSSKkkP2WmVDdpc_q71jYlQeVU_G3sHSTdj4kD9rqQl_91GX5Ryg63CIncUNPqEA532lXZsde39R3vOtdPiaPelpK9wKOnpANVz0l94_7hfdn5Bf4kdB-lNaeauzi3DjaqT81dF5RVChZwKVewZdLjSXx9LKh2JqLLnW3FER_oGY0-td6gaOoQ2llajtfBT9bhN_yE4X0vy3hpPg3YFsV9WJ-7Qra19SXcNh1GnlOZocHX_ePkr6bQ2IzzlYJdxzIV8Gktb5guTVGe5xEmegUKKXxPHe5E9yhIj4TepIzJ8d2nHuGnbC9SLfJoKor9xLLscbeMj8qgExmmjmditQYwQogc85yPiQsPkxle6lz7LhRqljTdqYQAAoBoEbwScWQfFjbXAShj1tHpxEjKm5hBaerIA7dasXXVj3BCcTln3bvIgwVvP24pKMrV7eNggSSSQlJH4x5EfC5vvqUcSnEaDwkH9eAvcOtvfq_4a_JYLVs3RugZivztn8dfwNAkjfc priority: 102 providerName: Unpaywall |
| Title | Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0002937819311652 https://dx.doi.org/10.1016/j.ajog.2019.09.036 https://www.ncbi.nlm.nih.gov/pubmed/31586602 https://www.proquest.com/docview/2301886756 http://repositorio.inen.pe:8080/handle/INEN/130 |
| UnpaywallVersion | publishedVersion |
| Volume | 222 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1097-6868 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002292 issn: 1085-8709 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect [Accès UNIL ; CHUV ; HEP Vaud ; Sites BCUL] customDbUrl: eissn: 1097-6868 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002292 issn: 1085-8709 databaseCode: ACRLP dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect (Elsevier) customDbUrl: eissn: 1097-6868 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002292 issn: 1085-8709 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1097-6868 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002292 issn: 1085-8709 databaseCode: AIKHN dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1097-6868 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002292 issn: 1085-8709 databaseCode: AKRWK dateStart: 19930101 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLamTeLyMHHdOmAyEm8QFseXJLxVE1MBreKBSuPJchwbOqVJ1cvQ9sB_4B9zTuIUEGIgpEppU5_UtY_PObY_f4eQZ1zGpTfWRBa8RyQyUUTGCxEVMHVIfZm7rF3QPx2r0US8PZNnW-S4PwuDsMpg-zub3lrrcOcotObRfDrFM74x-KoUXBpHDhm0w0KkmMXg5dcfMI8kyZM-BMbS4eBMh_Ey580nhHflHdep-pNz-j34vE1uruu5ufxiquonh3Ryh-yGSJIOu8reJVuuvkdunIa98vvkGwz9LmMobTw1mHh56WhL2LSk05oiqcgMnnsJHy4MotjpxZJiNi26MO3uDf2MNM_YPM0MS1GHbMjUtuYFvraoMYtXFGbs6woeij8DsnXZzKZXrqQBBl_B2zY5yAMyOXn94XgUhQQMkRWSrSLpJMRLJcus9SXLbVEYj-seqeEQBRZe5i53SjoksWfKpDlzWWKT3DNMXu0Vf0i266Z2-4igSrxlPi4h_hOGOcMVLwrFSoi_nJVyQFjf8toGdnJMklHpHoZ2rrG3NPaWjuHF1YA838jMO26Oa0vzvkN1f-oU7KQG13GtlNxI_aKXf5V72uuMhgGLuzCmds16qWHOx7IM5mlQZq9Tpk3tOZOZUnEyIC822vUPf-3gPyv5iNxKcPmghdQ9Jturxdo9gRhrVRy2g-iQ7AzfvBuN4ToZvx9-_A6QRyhi |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIlF6QDzb5VGMxA1CYzt2Em6oolqg21Mr9WY5jt1ulU1W-yhqD_0P_GNmEmcBVRSElEMensSxx_Owx98Q8kbIuPTGmsiC9oiSLCki45MkKsB1SH2Zu6yd0B8dquFx8uVEnqyRvX4vDIZVBtnfyfRWWoc7u6E1d6fjMe7xjUFXpaDSBGLIgBy-k0ieogf2_vpnnAfnOe9tYCweds50QV7mvDnF-K68AztVf9JON63PTbKxrKfm8pupql800v4Dcj-YkvRjV9uHZM3Vj8jdUVgsf0y-w9jvUobSxlODmZfnjraITXM6rimiikzgvZdwcWEwjJ1ezCmm06Iz0y7f0DPEecb2aSZYijqEQ6a2lS_w2CLLzD5QcNmXFbwUPwO0ddlMxleupCEOvoLTNjvIE3K8_-lobxiFDAyRTSRbRNJJMJhKllnrS5bbojAeJz5SI8AMLLzMXe6UdIhiz5RJc-YybnnuGWav9ko8Jet1U7ttDKHi3jIfl2AAJoY5I5QoCsVKMMCclXJAWN_y2gZ4csySUek-Du1cY29p7C0dwyHUgLxd0Uw7cI5bS4u-Q3W_7RQEpQbdcSuVXFH9xph_pXvd84yGEYvLMKZ2zXKuweljWQaOGpTZ6phpVXvBZKZUzAfk3Yq7_uHXnv1nJV-RjeHR6EAffD78-pzc4ziX0MbXvSDri9nSvQSDa1HstAPqB-hCKEc |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwELZGJ4F4YPwaFAEyEm-QrW5i1-FtmjYNpFV7oNJ4smzHhm5pMjXN0PZf8B9zF8cV0sQYUh9S1Zcmype77-zzd4S8T_mo8NrqxEL0SDKZmUT7LEsMpA4TX-ROdhP6x1NxNMu-nPLTDRI70-FEeTNHeYwaiKerIKcPyodBc2D38_Rgugtu9x7ZFBzI94BszqYne98iyYVgK2NJPSAx747zSSKkkP2WmVDdpc_q71jYlQeVU_G3sHSTdj4kD9rqQl_91GX5Ryg63CIncUNPqEA532lXZsde39R3vOtdPiaPelpK9wKOnpANVz0l94_7hfdn5Bf4kdB-lNaeauzi3DjaqT81dF5RVChZwKVewZdLjSXx9LKh2JqLLnW3FER_oGY0-td6gaOoQ2llajtfBT9bhN_yE4X0vy3hpPg3YFsV9WJ-7Qra19SXcNh1GnlOZocHX_ePkr6bQ2IzzlYJdxzIV8Gktb5guTVGe5xEmegUKKXxPHe5E9yhIj4TepIzJ8d2nHuGnbC9SLfJoKor9xLLscbeMj8qgExmmjmditQYwQogc85yPiQsPkxle6lz7LhRqljTdqYQAAoBoEbwScWQfFjbXAShj1tHpxEjKm5hBaerIA7dasXXVj3BCcTln3bvIgwVvP24pKMrV7eNggSSSQlJH4x5EfC5vvqUcSnEaDwkH9eAvcOtvfq_4a_JYLVs3RugZivztn8dfwNAkjfc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incidence+of+adverse+events+in+minimally+invasive+vs+open+radical+hysterectomy+in+early+cervical+cancer%3A+results+of+a+randomized+controlled+trial&rft.jtitle=American+journal+of+obstetrics+and+gynecology&rft.au=Obermair%2C+Andreas&rft.au=Asher%2C+Rebecca&rft.au=Pareja%2C+Rene&rft.au=Frumovitz%2C+Michael&rft.date=2020-03-01&rft.pub=Elsevier+Inc&rft.issn=0002-9378&rft.eissn=1097-6868&rft.volume=222&rft.issue=3&rft.spage=249.e1&rft.epage=249.e10&rft_id=info:doi/10.1016%2Fj.ajog.2019.09.036&rft.externalDocID=S0002937819311652 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9378&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9378&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9378&client=summon |